What is VRSK's health score?

Verisk Analytics, Inc. (VRSK) has a TradeApes health score of 72 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is VRSK's estimated fair value?

Based on our 5-year discounted cash flow model, Verisk Analytics, Inc.'s estimated fair value is $121.57 per share, representing a -32.5% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is VRSK undervalued or overvalued?

Our model currently rates VRSK as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for VRSK... Refresh in a moment for the full analysis.

Verisk Analytics, Inc. (VRSK)

Technology Overvalued low healthy

$180.0

Updated: 2026-06-04

TradeApes Score

Financial Strength

85 Strong

Operating Trend

60 Healthy

Relative Value

65 Healthy

Capital Allocation

80 Strong

Risk

70 Healthy

Est. Fair Value $121.57

DCF Upside -32.5%

Sector Rank #3946 of 7752

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− High P/E — 25–45×, growth premium already priced in

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.